Differences

This shows you the differences between two versions of the page.

--- home:mp [10.16.2017] – [In case of emergency] sallieq
+++ home:mp [03.12.2019] – [Endpoints of the Protocol] sallieq
@@ Line 28: / Line 28: @@
 ===== Background and scientific rationale for the therapy =====
-<relatedarticles> [[home:protocol#science_behind_marshall_pathogenesis|Science behind Marshall Pathogenesis]],  [[home:protocol#science_behind_marshall_protocol|Science behind Marshall Protocol]], [[home:mp:stages|Stages of illness and recovery]] </article>
+<relatedarticles>
+  * [[home:physicians:vitamin_d_leaflet|Testing your vitamin D metabolites]]
+  * [[home:pathogenesis|Science behind Marshall Pathogenesis]]
+  * [[home:protocol#science_behind_marshall_protocol|Science behind Marshall Protocol]]
+  * [[home:mp:stages|Stages of illness and recovery]]
+</article>
@@ Line 232: / Line 237: @@
 {{section>:home:patients:mp_duration#after_completion_of_the_marshall_protocol&noheader}}
+==== Data ====
+[[home:patients:cohort_statistics#later_information_2013|Success rates for various Dx, compiled in 2013]]
 ===== Stopping the Protocol =====
@@ Line 243: / Line 252: @@
 Olmesartan will need to be [[home:mp:break:olmesartan#stopping_olmesartan|weaned very gradually]]. Note that the immune response may remain activated for a period of time even after discontinuing olmesartan. Patients who stop olmesartan are terminating their recovery.
+{{tag>MP summary}}
 ===== Notes and comments =====

home/mp.txt · Last modified: 09.14.2022 by 127.0.0.1